Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

103 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids.
Nakayama T, Aizawa C, Kuno-Sakai H. Nakayama T, et al. Among authors: aizawa c. J Allergy Clin Immunol. 1999 Feb;103(2 Pt 1):321-5. doi: 10.1016/s0091-6749(99)70508-7. J Allergy Clin Immunol. 1999. PMID: 9949325
Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines.
Asahi Y, Yoshikawa T, Watanabe I, Iwasaki T, Hasegawa H, Sato Y, Shimada S, Nanno M, Matsuoka Y, Ohwaki M, Iwakura Y, Suzuki Y, Aizawa C, Sata T, Kurata T, Tamura S. Asahi Y, et al. Among authors: aizawa c. J Immunol. 2002 Mar 15;168(6):2930-8. doi: 10.4049/jimmunol.168.6.2930. J Immunol. 2002. PMID: 11884464
Characterization of protective immune responses induced by nasal influenza vaccine containing mutant cholera toxin as a safe adjuvant (CT112K).
Watanabe I, Hagiwara Y, Kadowaki SE, Yoshikawa T, Komase K, Aizawa C, Kiyono H, Takeda Y, McGhee JR, Chiba J, Sata T, Kurata T, Tamura S. Watanabe I, et al. Among authors: aizawa c. Vaccine. 2002 Oct 4;20(29-30):3443-55. doi: 10.1016/s0264-410x(02)00351-1. Vaccine. 2002. PMID: 12297389
Enhancement of immunoglobulin G responses in mice against hepatitis B virus surface antigen, influenza virus hemagglutinin vaccine, and tetanus toxoid by 6-O-acylated muramyl dipeptides.
Furuya T, Kumazawa Y, Takimoto H, Nagumo T, Watanabe M, Aizawa C, Kiso M, Hasegawa A, Nomoto K. Furuya T, et al. Among authors: aizawa c. Infect Immun. 1989 Jun;57(6):1839-44. doi: 10.1128/IAI.57.6.1839-1844.1989. Infect Immun. 1989. PMID: 2722242 Free PMC article.
Change in gelatin content of vaccines associated with reduction in reports of allergic reactions.
Nakayama T, Aizawa C. Nakayama T, et al. Among authors: aizawa c. J Allergy Clin Immunol. 2000 Sep;106(3):591-2. doi: 10.1067/mai.2000.108433. J Allergy Clin Immunol. 2000. PMID: 10984383 No abstract available.
Onjisaponins, from the root of Polygala tenuifolia Willdenow, as effective adjuvants for nasal influenza and diphtheria-pertussis-tetanus vaccines.
Nagai T, Suzuki Y, Kiyohara H, Susa E, Kato T, Nagamine T, Hagiwara Y, Tamura S, Yabe T, Aizawa C, Yamada H. Nagai T, et al. Among authors: aizawa c. Vaccine. 2001 Sep 14;19(32):4824-34. doi: 10.1016/s0264-410x(01)00215-8. Vaccine. 2001. PMID: 11535335
Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine.
Tamura SI, Asanuma H, Ito Y, Hirabayashi Y, Suzuki Y, Nagamine T, Aizawa C, Kurata T, Oya A. Tamura SI, et al. Among authors: aizawa c. Eur J Immunol. 1992 Feb;22(2):477-81. doi: 10.1002/eji.1830220228. Eur J Immunol. 1992. PMID: 1537382
Intranasal (i.n.) vs. subcutaneous (s.c.) administration of influenza hemagglutinin (HA) vaccine was systematically compared in BALB/c mice. ...The degree of protection was easily improved by i.n. inoculation of higher doses of vaccine, but not by the s.c. in …
Intranasal (i.n.) vs. subcutaneous (s.c.) administration of influenza hemagglutinin (HA) vaccine was systematically compared in BALB/ …
IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccinated by intranasal, intravenous and/or subcutaneous administration.
Asanuma H, Aizawa C, Kurata T, Tamura S. Asanuma H, et al. Among authors: aizawa c. Vaccine. 1998 Aug;16(13):1257-62. doi: 10.1016/s0264-410x(98)00048-6. Vaccine. 1998. PMID: 9682388
.), subcutaneous (s.c.) or intravenous (i.v.) vaccination and their combined vaccination of priming and boosting on a primary and a secondary IgA antibody forming cell (AFC) response were examined in the nasal associated lymphoid tissue (NALT), spleen and popliteal lymph n …
.), subcutaneous (s.c.) or intravenous (i.v.) vaccination and their combined vaccination of priming and boosting on a primary and a s …
Effects of frequent intranasal administration of adjuvant-combined influenza vaccine on the protection against virus infection.
Tamura S, Yajima A, Hatori E, Tamura S, Asanuma H, Suzuki Y, Aizawa C, Kurata T. Tamura S, et al. Among authors: aizawa c. Vaccine. 1997 Nov;15(16):1784-90. doi: 10.1016/s0264-410x(97)00113-8. Vaccine. 1997. PMID: 9364684
The present study was designed to determine whether the effectiveness of a combined LTB*-HA vaccine could be limited by preexisting immunity to LTB and how many times the adjuvant-combined vaccine could be administered intranasally without reducing its protective efficacy in BALB …
The present study was designed to determine whether the effectiveness of a combined LTB*-HA vaccine could be limited by preexisting immunity …
Suppression of delayed-type hypersensitivity and IgE antibody responses to ovalbumin by intranasal administration of Escherichia coli heat-labile enterotoxin B subunit-conjugated ovalbumin.
Tamura S, Hatori E, Tsuruhara T, Aizawa C, Kurata T. Tamura S, et al. Among authors: aizawa c. Vaccine. 1997 Feb;15(2):225-9. doi: 10.1016/s0264-410x(96)00135-1. Vaccine. 1997. PMID: 9066042
In the present experiments, whether nasal administration of allergen conjugated to Escherichia coli heat-labile toxin B subunit (LTB) induced tolerance was examined in BALB/c mice. ...
In the present experiments, whether nasal administration of allergen conjugated to Escherichia coli heat-labile toxin B subunit (LTB) induce …
103 results
Jump to page
Feedback